nav-left cat-right
cat-right

New Genome-Editing Method

A new startup, backed with $43 million in venture investments, aims to develop treatments that could cure inherited diseases with a one-time fix based on a new method of genome editing. The method offers great precision in changing the DNA sequence of a genome and can potentially treat diseases that other forms of gene therapy cannot. The new method, to be commercialized by Editas Medicine, is based on a genome-editing system...

FDA stops 23andMe from selling genetic kits

The Food and Drug Administration issued a warning letter to 23andMe CEO Ann Wojcicki on Friday, saying the company was selling its spit kits and Personal Genome Service without marketing clearance or approval in violation of the Federal Food, Drug and Cosmetic Act (the FD&C Act). The direct-to-consumer personalized genomics test is “intended for use in the diagnosis of disease or other conditions or in the cure,...

Myriad Releases Three New Tests

Myriad Genetics got their fair share of press this summer when the Supreme Court ruled that Myriad’s gene patents were invalid. But in the past three months, the company has released three diagnostic and prognostic tests. Patent or no patent, they’ve been busy. In the latest addition to their flurry of activity, this week Myriad launched myPath Melanoma, a diagnostic test meant to effectively differentiate malignant...

Biodatomics’ Open Source Approach

Maxim Mikheev is a co-founder and CEO of Biodatomics, gene informatics software companies. Mikheev is a molecular biologist, computer programmer, and aggressive entrepreneur. More uniquely, he is also an active member of the open source community, and BioDT, the platform his company unveiled two weeks ago at the ASHG conference in Boston, is open source from top to bottom. None of the roughly 400 distinct tools included in...

Amazon, Baylor and DNAnexus team up for huge seque...

The scale of genomics sequencing projects continues to grow rapidly. Just as the 1,000 Genomes Project once dwarfed the Human Genome Project, now an initiative involving Amazon ($AMZN), Baylor College of Medicine and DNAnexus has surpassed both of them, generating 430 terabytes of data in the process. Amazon, Baylor and DNAnexus came together to contribute to the Cohorts for Heart and Aging Research in Genomic Epidemiology...

Nigeria: FG and Cost of Cancer Screening

THE Federal Government’s recent directive to its hospitals to reduce the cost of cancer screening, though very commendable, is long overdue, considering that late diagnosis of the disease has resulted in the high rate of cancer related deaths in the country. Cancer is one of the leading causes of deaths in the world, especially in developing countries, which carry about 80 per cent of the burden, globally....
Page 5 of 8« First...34567...Last »